RKDA Short Volume
Arcadia Biosciences, Inc. (RKDA) operates in the Basic Materials sector, specifically the Agricultural Inputs industry, with a market capitalization near $796,095, listed on NASDAQ, employing roughly 8 people, carrying a beta of 0.55 to the broader market. Arcadia Biosciences, Inc. Led by Thomas J. Schaefer, public since 2015-05-15.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-08-28
- Short Volume
- 36.4K
- Total Volume
- 105.5K
- Short %
- 34.49%
- 30-Day Avg Short %
- 27.81%
Showing 30 days of FINRA short volume data for Arcadia Biosciences, Inc..
Learn how short volume is reported and how to read the data →
Frequently asked RKDA short volume questions
- What is the daily RKDA short volume?
- As of Aug 28, 2026, Arcadia Biosciences, Inc. (RKDA) short volume is 36.4K shares against 105.5K total reported volume, or 34.49% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is RKDA short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does RKDA short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.